Tiktok Youtube Telegram Instagram Linkedin X-twitter
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • LBNN Blueprints
  • Quizzes
    • Enneagram quiz
  • Newsletters
    • LBNN Newsletter
    • Divergent Capitalist
  • Fashion Intelligence
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • LBNN Blueprints
  • Quizzes
    • Enneagram quiz
  • Newsletters
    • LBNN Newsletter
    • Divergent Capitalist
  • Fashion Intelligence

Muscle-sparing obesity drug safe for Phase 3 trial, Veru says

Simon Osuji by Simon Osuji
May 28, 2025
in Technology
0
Muscle-sparing obesity drug safe for Phase 3 trial, Veru says
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

Related posts

Govt unveils first treatment facility to eliminate harmful chemicals, protect public health, environment – EnviroNews

Govt unveils first treatment facility to eliminate harmful chemicals, protect public health, environment – EnviroNews

December 19, 2025
Metsera strengthens case for Pfizer buyout with latest study data

Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial

December 18, 2025

Source link

Previous Post

GPT-4o exhibits humanlike cognitive dissonance, study finds

 Next Post

Karat Financial is bringing business banking to creators
Next Post
Karat Financial is bringing business banking to creators

Karat Financial is bringing business banking to creators

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

Digital replicas of real world could help decarbonise transport, scientists say

Digital replicas of real world could help decarbonise transport, scientists say

1 year ago
Eskom given financial statements exemption over credit rating fears

Eskom given financial statements exemption over credit rating fears

2 years ago
Top 10 African countries with the lowest cost of goods and services in 2025

Top 10 African countries with the lowest cost of goods and services in 2025

7 months ago
Raytheon Wins $100M HC-130J Combat King II Aircraft Support Contract

Raytheon Wins $100M HC-130J Combat King II Aircraft Support Contract

9 months ago

POPULAR NEWS

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0

  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0

  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0

  • Global ranking of Top 5 smartphone brands in Q3, 2024

    0 shares
    Share 0 Tweet 0

  • When Will SHIB Reach $1? Here’s What ChatGPT Says

    0 shares
    Share 0 Tweet 0

Get strategic intelligence you won’t find anywhere else. Subscribe to the Limitless Beliefs Newsletter for monthly insights on overlooked business opportunities across Africa.

Subscription Form
© 2023 LBNN – All rights reserved.

Privacy Policy | About Us | Contact

Tiktok Youtube Telegram Instagram Linkedin X-twitter
No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • LBNN Blueprints
  • Quizzes
    • Enneagram quiz
  • Newsletters
    • LBNN Newsletter
    • Divergent Capitalist
  • Fashion Intelligence

© 2023 LBNN - All rights reserved.